Leucine-Based Polymer Architecture-Induced Antimicrobial Properties and Bacterial Cell Morphology Switching

ACS Omega
Ishita MukherjeePriyadarsi De

Abstract

To evaluate the comparative antibacterial activity of leucine-based cationic polymers having linear, hyperbranched, and star architectures containing both hydrophilic and hydrophobic segments against Gram-negative bacterium, Escherichia coli (E. coli), herein we performed zone of inhibition study, minimum inhibitory concentration (MIC) calculation, and bacterial growth experiment. The highest antibacterial activity in terms of the MIC value was found in hyperbranched and star architectures because of the greater extent of cationic and hydrophobic functionality, enhancing cell wall penetration ability compared to that of the linear polymer. The absence of the bacterial regrowth stage in the growth curve exhibited the highest bactericidal capacity of star polymers, when untreated cells (control) already reached to the stationary phase, whereas the bacterial regrowth stage with a delayed lag phase was critically observed for linear and hyperbranched architectures displaying lower bactericidal efficacy. Coagulation of E. coli cells, switching of cell morphology from rod to sphere, and lengthening due to stacking in an antimicrobial polymer-treated environment at the bacterial regrowth stage in liquid media were visualized criticall...Continue Reading

References

Feb 8, 1997·Lancet·R E Hancock
Mar 6, 1998·Trends in Biotechnology·R E Hancock, R Lehrer
May 9, 1998·Applied and Environmental Microbiology·P LebaronP Catala
Jan 5, 2002·International Journal of Food Microbiology·T P RobinsonB M Mackey
Jan 25, 2002·Nature·Michael Zasloff
Apr 6, 2002·International Journal of Food Microbiology·József Baranyi
Dec 2, 2004·Journal of the American Chemical Society·M Firat IlkerE Bryan Coughlin
Feb 11, 2005·Nature Reviews. Microbiology·Kim A Brogden
Mar 24, 2005·Journal of the American Chemical Society·Kenichi Kuroda, William F DeGrado
Jun 1, 1990·Applied and Environmental Microbiology·M H ZwieteringK van 't Riet
Jul 4, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Colin W Pouton
Dec 13, 2006·Nature Biotechnology·Robert E W Hancock, Hans-Georg Sahl
Jan 9, 2007·Biomacromolecules·Philippe H SellenetJeffrey P Youngblood
Apr 7, 2007·Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society·Ulkü Yapucu Güneş, Ismet Eşer
Sep 20, 2007·Biomacromolecules·Bradley C AllisonJeffrey P Youngblood
Nov 24, 2007·Journal of the American Chemical Society·Brendan P MowerySamuel H Gellman
Jul 3, 2008·Journal of the American Chemical Society·Karen LienkampGregory N Tew
Oct 28, 2008·Biochimica Et Biophysica Acta·Katsumi Matsuzaki
Jul 16, 2009·Journal of the American Chemical Society·Brendan P MowerySamuel H Gellman
Sep 19, 2009·Science·Hubert LamMatthew K Waldor
Jun 22, 2010·Applied Microbiology and Biotechnology·Edmund F Palermo, Kenichi Kuroda
Oct 19, 2010·Applied Microbiology and Biotechnology·Larisa Timofeeva, Natalia Kleshcheva
Jul 23, 2011·Chemical Communications : Chem Comm·Shruti PadheeJianfeng Cai
Aug 19, 2011·Biomacromolecules·Yukari OdaKenichi Kuroda
Jan 26, 2013·Langmuir : the ACS Journal of Surfaces and Colloids·Kamal BauriPriyadarsi De
Oct 9, 2013·Biomacromolecules·Katherine E S LocockMatthias Haeussler
May 24, 2014·Chemical Communications : Chem Comm·Ashish PuniaNan-Loh Yang
Apr 17, 2015·ACS Chemical Biology·Michael J WilhelmHai-Lung Dai
Jul 23, 2015·Biomacromolecules·Diep NguyenCyrille Boyer
Apr 1, 2016·Biomacromolecules·Fengyu SheJianfeng Cai
Jul 14, 2016·Biomacromolecules·Amanda C HarveySteven P Armes
Dec 13, 2016·Biomaterials·Alaa S Abd-El-AzizNola Etkin
Jan 10, 2017·Biomacromolecules·Alekhya NimmagaddaJianfeng Cai

❮ Previous
Next ❯

Methods Mentioned

BETA
scanning
fluorescence microscopy
Assay

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.